News from the Danish Medicines Agency
-
Risk of supply failure: Use protective equipment rationally
| 22 March 2020 |
There is a risk that the healthcare sector will run out of protective equipment, such as hand sanitizer, facemasks and visors/shields, which are crucial in the fight against coronavirus. We urge everyone to use at little as possible without compromising on safety.
-
Global action against illicit medicines and medical devices
| 20 March 2020 |
The global action Operation Pangea targeting the illicit sale of medicines and medical devices has now finished, and the results have been established. 635 parcels containing illegally imported medicines were seized in Denmark.
-
Restriction on sale of medicines in pharmacies (clarification)
| 19 March 2020 |
The Minister of Health has activated parts of the drug preparedness. This means that you cannot buy more prescription medicines at the pharmacy than what you normally use, and that the amount of OTC medicines being dispensed has been limited. The decision has been taken to avoid hoarding.
-
All efforts taken to minimise supply disruption of medicines and medical devices
| 10 March 2020 |
Authorities and companies in Denmark and abroad are collaborating intensively to minimise potential disruptions in the supply chain of medicines and medical devices caused by the COVID-19 outbreak.
-
New enhanced reporting requirement is to strengthen the surveillance of medical devices
| 05 March 2020 |
A new rule imposing an enhanced reporting requirement on medical devices has just entered into force. The rule is to ensure that the surveillance of medical devices is strengthened and becomes more focused for the benefit of patients.
-
New head of the Danish Medicines Agency’s Data Analytics Centre
| 05 March 2020 |
The Danish Medicines Agency has hired Jesper Kjær as head of the Agency’s Data Analytics Centre as of 1 April. The Data Analytics Centre will officially open later this year.
-
The authorities are getting ready for fast-track approval of vaccines for coronavirus
| 17 February 2020 |
Drug regulatory authorities around the world are supporting researchers and companies in the fast development of a vaccine for coronavirus (2019-nCoV) and are getting ready to facilitate an approval as fast as possible without compromising safety.
-
Danish Medicines Agency's top priorities in 2020
| 08 January 2020 |
A data-driven medicines agency, the continued supply of medicines, a great place to work and productivity and quality are the top priorities for the Danish Medicines Agency in 2020.